Filing
Spy
Filing
Spy
Home
About
ZNTL
Zentalis Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 98943L107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2021 Q2
5 of 9 quarters
Total Value
$127.64M
Total Shares
2.40M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$127.64M
2.40M
0.4%
Unchanged
Viking Global Investors
$127.64M
2.40M shares
Unchanged
ZNTL — Zentalis Pharmaceuticals Inc - FilingSpy